REAL-WORLD USE OF ONCE-WEEKLY SEMAGLUTIDE BY BASELINE ESTIMATED GLOMERULAR FILTRATION RATE-A POST-HOC ANALYSIS OF POOLED DATA FROM THE SURE STUDIES (CANADA, DENMARK/SWEDEN, SWITZERLAND AND UK)

被引：0
|
作者：
Rudofsky, Gottfried [1 ,8 ]
Catarig, Andrei-Mircea [2 ]
Erhan, Umut [3 ]
Jain, Rashmi [4 ]
Knudsen, Soren Tang [5 ]
Saravanan, Ponnusamy [6 ]
Yale, Jean-Francois [7 ]
机构：
[1] Cantonal Hosp, Olten, Switzerland
[2] Novo Nordisk AS, Soborg, Denmark
[3] Novo Nordisk AS, Copenhagen, Denmark
[4] Novo Nordisk Serv Ctr India Private Ltd, Bengaluru, India
[5] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus SDCA, Aarhus, Denmark
[6] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[7] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[8] Praxis Endokrinol Diabet & Adipositas, Olten, Switzerland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FC 124
引用
收藏
页码：I894 / I895
页数：2
相关论文
共 14 条
  • [1] Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups
    Yale, Jean-Francois
    Bodholdt, Ulrik
    Catarig, Andrei-Mircea
    Catrina, Sergiu
    Clark, Alice
    Ekberg, Neda Rajamand
    Erhan, Umut
    Holmes, Patrick
    Knudsen, Soren Tang
    Liutkus, Joanne
    Sathyapalan, Thozhukat
    Schultes, Bernd
    Rudofsky, Gottfried
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (02)
  • [2] Real-world safety profile of once-weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real-world Evidence (SURE) programme
    Yale, Jean-Francois
    Major-Pedersen, Atheline
    Catarig, Andrei-Mircea
    Jain, Rashmi
    Menzen, Markus
    Holmes, Patrick
    [J]. DIABETES OBESITY & METABOLISM, 2024,
  • [3] Real-world use of once-weekly semaglutide in type 2 diabetes: Results from the SURE UK study
    Holmes, P.
    Catarig, A. M.
    Clark, A.
    Erhan, U.
    Sathyapalan, T.
    [J]. DIABETIC MEDICINE, 2021, 38
  • [4] Patients reaching treatment targets with once-weekly semaglutide in real-world practice: pooled analysis of four SURE studies
    Rudofsky, G.
    Bodholdt, U.
    Catarig, A. -M.
    Ekberg, N. Rajamand
    Erhan, U.
    Liutkus, J. F.
    Tariq, M.
    Holmes, P.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 230 - 231
  • [5] Real-world use of once-weekly semaglutide in diverse patient populations with type 2 diabetes: pooled analysis of four SURE studies
    Yale, J. -F.
    Catarig, A. -M.
    Catrina, S. -B.
    Erhan, U.
    Sathyapalan, T.
    Schultes, B.
    Tariq, M.
    Knudsen, S. T.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 230 - 230
  • [6] Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study
    Ekberg, Neda Rajamand
    Bodholdt, Ulrik
    Catarig, Andrei-Mircea
    Catrina, Sergiu-Bogdan
    Grau, Katrine
    Holmberg, Cecilia Nagorny
    Klanger, Boris
    Knudsen, Soren Tang
    [J]. PRIMARY CARE DIABETES, 2021, 15 (05) : 871 - 878
  • [7] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Wolffenbuttel, Bruce H. R.
    Brugts, Michel P.
    Catarig, Andrei-Mircea
    Clark, Alice
    Kok, Maarten
    Lieverse, Aloysius G.
    van Soest, Jaap
    [J]. ADVANCES IN THERAPY, 2023, 40 (03) : 920 - 933
  • [8] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Bruce H. R. Wolffenbuttel
    Michel P. Brugts
    Andrei-Mircea Catarig
    Alice Clark
    Maarten Kok
    Aloysius G. Lieverse
    Jaap van Soest
    [J]. Advances in Therapy, 2023, 40 : 920 - 933
  • [9] Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study
    Napoli, Raffaele
    Berra, Cesare
    Catarig, Andrei-Mircea
    Di Loreto, Chiara
    Donatiello, Emily
    Berentzen, Tina Landsvig
    Pitocco, Dario
    Giorgino, Francesco
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1658 - 1667
  • [10] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Holmes, Patrick
    Bell, Heather Elizabeth
    Bozkurt, Karan
    Catarig, Andrei-Mircea
    Clark, Alice
    Machell, Alena
    Sathyapalan, Thozhukat
    [J]. DIABETES THERAPY, 2021, 12 (11) : 2891 - 2905
12